[10] Die Beurteilung der EMA ist in bereinstimmung mit den vorlufigen Ergebnissen einer laufenden Bewertung der US-Behrde FDA, die ebenfalls keinen Zusammenhang fand
Benefits and Safety Introduction Finding a weight loss strategy that works for the long term can feel like a constant cycle of progress followed by a sudden wall
Semaglutide, marketed under names like Ozempic, Rybelsus, Wegovy, Trulicity, and Mounjaro, has transformed the treatment landscape for type 2 diabetes and obesity due to its effectiveness
Durability While the STEP 1 trial extension [10] revealed substantial weight loss after 68 weeks of semaglutide use, weight regain was observed upon discontinuation of the drug, see Figure 1
Gastrointestinal effects are the most commonly reported side effects, affecting the majority of users to some degree